Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Vose

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphomaLanfang Li, Philip Bierman, Julie Vose, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 30, 2009
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphomaNilesh W Gaikwad, Li Yang, Dennis D Weisenburger, et al.
Veterinary Parasitology|August 28, 2019
The effect of enterococci on feline Tritrichomonas foetus infection in vitroRachel Dickson, Julie Vose, David Bemis, et al.
American Journal of Hematology|September 8, 2011
Non-Hodgkin lymphoma of the prostateJohn Steuter, Dennis D Weisenburger, R Greg Bociek, et al.
Journal of Veterinary Internal Medicine|February 13, 2019
The frequency of oral famotidine administration influences its effect on gastric pH in cats over timeElizabeth Golly, Adesola Odunayo, Maggie Daves, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2014
Utility of prechemotherapy evaluation of left ventricular function for patients with lymphomaJohn Steuter, Robert Bociek, Fausto Loberiza, et al.
Radiology|February 9, 2016
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringRyogo Minamimoto, Luis Fayad, Ranjana Advani, et al.
Future Oncology (London, England)|November 11, 2021
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?Prajwal Dhakal, Christopher S Wichman, Bunny Pozehl, et al.
British Journal of Haematology|December 6, 2008
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary componentJamil Y Abuzetun, Fausto Loberiza, Julie Vose, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphomaTheresa Hahn, Steven N Wolff, Myron Czuczman, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphomaLanfang Li, Philip Bierman, Julie Vose, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 30, 2009
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphomaNilesh W Gaikwad, Li Yang, Dennis D Weisenburger, et al.
Veterinary Parasitology|August 28, 2019
The effect of enterococci on feline Tritrichomonas foetus infection in vitroRachel Dickson, Julie Vose, David Bemis, et al.
American Journal of Hematology|September 8, 2011
Non-Hodgkin lymphoma of the prostateJohn Steuter, Dennis D Weisenburger, R Greg Bociek, et al.
Journal of Veterinary Internal Medicine|February 13, 2019
The frequency of oral famotidine administration influences its effect on gastric pH in cats over timeElizabeth Golly, Adesola Odunayo, Maggie Daves, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2014
Utility of prechemotherapy evaluation of left ventricular function for patients with lymphomaJohn Steuter, Robert Bociek, Fausto Loberiza, et al.
Radiology|February 9, 2016
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringRyogo Minamimoto, Luis Fayad, Ranjana Advani, et al.
Future Oncology (London, England)|November 11, 2021
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?Prajwal Dhakal, Christopher S Wichman, Bunny Pozehl, et al.
British Journal of Haematology|December 6, 2008
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary componentJamil Y Abuzetun, Fausto Loberiza, Julie Vose, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphomaTheresa Hahn, Steven N Wolff, Myron Czuczman, et al.
Pageof 7